GMED
Income statement / Annual
Last year (2023), Globus Medical, Inc.'s total revenue was $1.57 B,
an increase of 53.34% from the previous year.
In 2023, Globus Medical, Inc.'s net income was $122.87 M.
See Globus Medical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$1.57 B
|
$1.02 B
|
$958.10 M
|
$789.04 M
|
$785.37 M
|
$712.97 M
|
$635.98 M
|
$563.99 M
|
$544.75 M
|
$474.37 M
|
| Cost of Revenue |
$548.17 M |
$263.73 M |
$239.22 M |
$217.46 M |
$179.98 M |
$159.41 M |
$150.45 M |
$134.71 M |
$132.80 M |
$110.86 M |
| Gross Profit |
$1.02 B |
$759.12 M |
$718.88 M |
$571.58 M |
$605.39 M |
$553.56 M |
$485.52 M |
$429.29 M |
$411.95 M |
$363.51 M |
| Gross Profit Ratio |
0.65 |
0.74 |
0.75 |
0.72 |
0.77 |
0.78 |
0.76 |
0.76 |
0.76 |
0.77 |
| Research and Development
Expenses |
$124.01 M
|
$73.02 M
|
$97.35 M
|
$84.52 M
|
$60.07 M
|
$55.50 M
|
$43.68 M
|
$44.53 M
|
$36.98 M
|
$31.69 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$311.59 M
|
$267.82 M
|
$222.16 M
|
$214.01 M
|
$187.80 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$643.41 M
|
$432.12 M
|
$408.15 M
|
$354.76 M
|
$354.76 M
|
$311.59 M
|
$267.82 M
|
$222.16 M
|
$214.01 M
|
$187.80 M
|
| Other Expenses |
$767.42 M |
$17.74 M |
$18.53 M |
$16.83 M |
$13.81 M |
$19.28 M |
$8.09 M |
$3.14 M |
$583,000.00 |
$280,000.00 |
| Operating Expenses |
$818.45 M |
$522.87 M |
$524.02 M |
$456.11 M |
$428.64 M |
$376.68 M |
$319.41 M |
$270.17 M |
$251.00 M |
$219.49 M |
| Cost And Expenses |
$1.37 B |
$786.59 M |
$763.24 M |
$673.57 M |
$608.61 M |
$536.09 M |
$469.86 M |
$404.87 M |
$383.80 M |
$330.34 M |
| Interest Income |
$20.13 M |
$14.23 M |
$9.30 M |
$13.95 M |
$17.41 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$20.13 M |
$14.23 M |
$9.30 M |
$13.95 M |
-$17.41 M |
-$13.28 M |
-$6.61 M |
-$3.06 M |
-$1.30 M |
-$805,000.00 |
| Depreciation &
Amortization |
$144.73 M
|
$68.25 M
|
$69.87 M
|
$62.87 M
|
$52.73 M
|
$41.63 M
|
$42.07 M
|
$38.77 M
|
$24.08 M
|
$21.75 M
|
| EBITDA |
$401.03 M
|
$313.82 M
|
$289.05 M
|
$182.66 M
|
$229.96 M
|
$226.07 M
|
$212.47 M
|
$202.88 M
|
$173.77 M
|
$171.45 M
|
| EBITDA Ratio |
0.26 |
0.31 |
0.3 |
0.23 |
0.29 |
0.32 |
0.33 |
0.36 |
0.32 |
0.36 |
| Operating Income Ratio
|
0.08
|
0.22
|
0.18
|
0.14
|
0.22
|
0.24
|
0.25
|
0.27
|
0.32
|
0.29
|
| Total Other
Income/Expenses Net |
$165.39 M
|
$15.07 M
|
$8.45 M
|
$14.47 M
|
$17.96 M
|
$11.72 M
|
$3.81 M
|
-$1.84 M
|
$11.85 M
|
-$5.39 M
|
| Income Before Tax |
$165.39 M |
$243.02 M |
$180.41 M |
$125.90 M |
$189.95 M |
$188.61 M |
$169.93 M |
$157.28 M |
$172.81 M |
$138.64 M |
| Income Before Tax Ratio
|
0.11
|
0.24
|
0.19
|
0.16
|
0.24
|
0.26
|
0.27
|
0.28
|
0.32
|
0.29
|
| Income Tax Expense |
$42.52 M |
$52.85 M |
$31.22 M |
$23.61 M |
$34.74 M |
$32.13 M |
$62.58 M |
$52.94 M |
$60.02 M |
$46.16 M |
| Net Income |
$122.87 M |
$190.17 M |
$149.19 M |
$102.29 M |
$155.21 M |
$156.47 M |
$107.35 M |
$104.34 M |
$112.78 M |
$92.49 M |
| Net Income Ratio |
0.08 |
0.19 |
0.16 |
0.13 |
0.2 |
0.22 |
0.17 |
0.19 |
0.21 |
0.19 |
| EPS |
1.09 |
1.89 |
1.48 |
1.04 |
1.57 |
1.6 |
1.12 |
1.09 |
1.19 |
0.98 |
| EPS Diluted |
1.07 |
1.85 |
1.44 |
1.01 |
1.52 |
1.54 |
1.1 |
1.08 |
1.17 |
0.97 |
| Weighted Average Shares
Out |
$113.09 M
|
$100.47 M
|
$100.73 M
|
$98.58 M
|
$99.15 M
|
$97.88 M
|
$96.24 M
|
$95.65 M
|
$95.05 M
|
$94.23 M
|
| Weighted Average Shares
Out Diluted |
$114.63 M
|
$102.64 M
|
$103.62 M
|
$100.97 M
|
$102.00 M
|
$101.32 M
|
$97.89 M
|
$96.43 M
|
$96.07 M
|
$95.46 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
